Back to today’s briefing

Story perspectives

Study Links Ozempic to Doubled Risk of Serious Eye Condition

1/4/2025

36 5

Summary

Story summary

Recent research from the University of Southern Denmark reveals a concerning link between Ozempic, a diabetes medication, and a doubled risk of non-arteritic anterior ischemic optic neuropathy (NAION), a serious eye condition. Though the overall risk remains low, these findings underscore the importance of open conversations between patients and doctors about the medication's potential benefits and risks.

1 of 1

Story summary

Recent research from the University of Southern Denmark reveals a concerning link between Ozempic, a diabetes medication, and a doubled risk of non-arteritic anterior ischemic optic neuropathy (NAION), a serious eye condition. Though the overall risk remains low, these findings underscore the importance of open conversations between patients and doctors about the medication's potential benefits and risks.